Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
Clinical trial NCT03844945 · COMPLETED
Trial details
- NCT number
- NCT03844945
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2019-09-19
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.